The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant androgen deprivation therapy with enzalutamide plus the glucocorticoid receptor modulator relacorilant versus placebo for patients with high-risk localized prostate cancer.
 
Mohammad Atiq
Honoraria - DAVA Oncology; Health Monitor Network, LLC; MJH Life Sciences
 
Walter Stadler
Stock and Other Ownership Interests - Fortress Biotech
Consulting or Advisory Role - AstraZeneca; Aveo; CVS Caremark; Merck; Pfizer; Treadwell Therapeutics; Xencorp
Research Funding - Abbvie (Inst); Amgen (Inst); Astellas Medivation (Inst); AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Corvus Pharmaceuticals (Inst); Eisai (Inst); Exelixis (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Johnson & Johnson (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); Seagen (I); Tesaro (Inst); X4 Pharma (Inst); Xencor (Inst)
Expert Testimony - Apotex; Sandoz; US Dept of Justice; US Dept of Justice
Other Relationship - American Cancer Society; UpToDate
 
Ashley Page
Employment - University of Chicago
 
Meghan Catenacci
No Relationships to Disclose
 
Akash Patnaik
Stock and Other Ownership Interests - Gilead Sciences; Infinity Pharmaceuticals; Merck; Merck
Honoraria - BostonGene; Medscape; Prime Oncology
Consulting or Advisory Role - Curio Science; Exelixis; Gerson Lehrman Group; Guidepoint Pharmacy
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Laekna Health Care (Inst); Progenics (Inst); Xencor (Inst); Zenith Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Exelixis; Prime Oncology
 
Gladell Paner
No Relationships to Disclose
 
Scott Eggener
No Relationships to Disclose
 
Russell Szmulewitz
Consulting or Advisory Role - Amgen; Bayer; Eisai; Janssen Oncology; Merck; Novartis; Sanofi
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); Bayer (Inst); Janssen Oncology (Inst); Janux Therapeutics (Inst); Merck (Inst); Novartis (Inst); Nurix (Inst); Progenics (Inst)
Patents, Royalties, Other Intellectual Property - Patent licensed by University of Chicago of which I am co-inventor to Corcept Therapeutics for combination AR/GR inhibition in prostate cancer
Travel, Accommodations, Expenses - DAVA Oncology